Cargando…

Current treatment status of IgA nephropathy in Japan: a questionnaire survey

BACKGROUND: In 2020, the Committee of Clinical Practical Guideline for IgA Nephropathy (IgAN) revised the clinical practice guidelines. Herein, we conducted a questionnaire survey to assess the potential discrepancies between clinical practice guidelines and real-world practice in Japan. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuzaki, K., Suzuki, H., Kikuchi, M., Koike, K., Komatsu, H., Takahashi, K., Narita, I., Okada, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654181/ https://www.ncbi.nlm.nih.gov/pubmed/37646957 http://dx.doi.org/10.1007/s10157-023-02396-0

Ejemplares similares

Nationwide survey on current treatments for IgA nephropathy in Japan
por: Matsuzaki, Keiichi, et al.
Publicado: (2013)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

Utility of remission criteria for the renal prognosis of IgA nephropathy
por: Matsuzaki, Keiichi, et al.
Publicado: (2021)

Diagnosis and treatment of patients with IgA nephropathy in Japan
por: Tomino, Yasuhiko
Publicado: (2016)

Associations of corticosteroid therapy and tonsillectomy with kidney survival in a multicenter prospective study for IgA nephropathy
por: Kawamura, Tetsuya, et al.
Publicado: (2023)

Changes in Nephritogenic Serum Galactose-Deficient IgA1 in IgA Nephropathy following Tonsillectomy and Steroid Therapy
por: Nakata, Junichiro, et al.
Publicado: (2014)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

IgA Nephropathy with Dominant IgA2 Deposition Accompanied by Mantle Cell Lymphoma
por: Kakeshita, Kota, et al.
Publicado: (2020)

Complement activation in IgA nephropathy
por: Medjeral-Thomas, Nicholas R., et al.
Publicado: (2021)

Comparative proteomic analysis of glomerular proteins in IgA nephropathy and IgA vasculitis with nephritis
por: Kaga, Hajime, et al.
Publicado: (2023)

IgA Nephropathy: Current Treatment and New Insights
por: Petrou, Dimitra, et al.
Publicado: (2023)

Glomerular tip adhesions predict the progression of IgA nephropathy
por: Maeda, Kunihiro, et al.
Publicado: (2013)

Idiopathic erythrocytosis in IgA nephropathy
por: Mahesh, E., et al.
Publicado: (2017)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy
por: Aizawa, Masashi, et al.
Publicado: (2014)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy
por: Placzek, William J., et al.
Publicado: (2018)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Primary IgA nephropathy: current challenges and future prospects
por: Penfold, Rose S, et al.
Publicado: (2018)

Clinical Significance of the Intensity of Glomerular Galactose-Deficient IgA1 Deposition in IgA Nephropathy
por: Nakayama, Maiko, et al.
Publicado: (2022)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
por: Fukao, Yusuke, et al.
Publicado: (2022)

Ethnicity and IgA nephropathy: worldwide differences in epidemiology, timing of diagnosis, clinical manifestations, management and prognosis
por: Lee, Mingfeng, et al.
Publicado: (2023)

Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy
por: Yasutake, Junichi, et al.
Publicado: (2015)

Galactose-Deficient IgA1 as a Candidate Urinary Polypeptide Marker of IgA Nephropathy?
por: Suzuki, Hitoshi, et al.
Publicado: (2016)

An adolescent girl diagnosed with IgA nephropathy following the first dose of the COVID-19 vaccine
por: Okada, Mari, et al.
Publicado: (2022)

Glomerular solidification is associated with nephritis-related clinical parameters in IgA nephropathy
por: Inoue, Tsutomu, et al.
Publicado: (2019)

IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
por: Sukcharoen, Kittiya, et al.
Publicado: (2020)

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports
por: Tota, Maciej, et al.
Publicado: (2023)

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
por: Berthelot, Laureline, et al.
Publicado: (2012)

cnm-positive Streptococcus mutans is associated with galactose-deficient IgA in patients with IgA nephropathy
por: Misaki, Taro, et al.
Publicado: (2023)

Renal pathological analysis using galactose-deficient IgA1-specific monoclonal antibody is a strong tool for differentiation of primary IgA nephropathy from secondary IgA nephropathy
por: Lee, Mingfeng, et al.
Publicado: (2020)

Enzymatic Sialylation of IgA1 O-Glycans: Implications for Studies of IgA Nephropathy
por: Takahashi, Kazuo, et al.
Publicado: (2014)

POS-887 GROSS HEMATURIA AFTER SARS-CoV-2 VACCINATION: QUESTIONNAIRE SURVEY IN JAPAN
por: AOKI, R., et al.
Publicado: (2022)

Spontaneous remission in adult patients with IgA nephropathy treated with conservative therapy
por: Sato, Hirotaka, et al.
Publicado: (2021)

Thrombotic Microangiopathy in IgA Nephropathy
por: Nasri, Hamid
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jj526p7bq9ekvgm06arqujj4lk